BACK TO ALL

ALEX MARSON, M.D., PH.D.

Marson is developing genome editing technologies to understand how sequence variation in the human genome alters and controls T cell immune function. He aims to engineer a new generation of targeted therapies for autoimmune disorders, immunodeficiencies, and infectious diseases.

Photo of ALEX MARSON, M.D., PH.D.